Clinical Trial Update: Role of Gene Variation in Effectiveness of Gleevec Treatment

View source ↗

Summary

A completed clinical trial evaluated whether genetic variation influences the effectiveness of imatinib (Gleevec) in cancer, including breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gleevec (Imatinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cancer, Breast Cancer | Status: COMPLETED